These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

309 related items for PubMed ID: 17667530

  • 1. Effective clinical-scale production of dendritic cell vaccines by monocyte elutriation directly in medium, subsequent culture in bags and final antigen loading using peptides or RNA transfection.
    Erdmann M, Dörrie J, Schaft N, Strasser E, Hendelmeier M, Kämpgen E, Schuler G, Schuler-Thurner B.
    J Immunother; 2007 Sep; 30(6):663-74. PubMed ID: 17667530
    [Abstract] [Full Text] [Related]

  • 2. Efficient elutriation of monocytes within a closed system (Elutra) for clinical-scale generation of dendritic cells.
    Berger TG, Strasser E, Smith R, Carste C, Schuler-Thurner B, Kaempgen E, Schuler G.
    J Immunol Methods; 2005 Mar; 298(1-2):61-72. PubMed ID: 15847797
    [Abstract] [Full Text] [Related]

  • 3. Closing the manufacturing process of dendritic cell vaccines transduced with adenovirus vectors.
    Gulen D, Abe F, Maas S, Reed E, Cowan K, Pirruccello S, Wisecarver J, Warkentin P, Northam M, Turken O, Coskun U, Senesac J, Talmadge JE.
    Int Immunopharmacol; 2008 Dec 20; 8(13-14):1728-36. PubMed ID: 18793758
    [Abstract] [Full Text] [Related]

  • 4. Electroporation of immature and mature dendritic cells: implications for dendritic cell-based vaccines.
    Michiels A, Tuyaerts S, Bonehill A, Corthals J, Breckpot K, Heirman C, Van Meirvenne S, Dullaers M, Allard S, Brasseur F, van der Bruggen P, Thielemans K.
    Gene Ther; 2005 May 20; 12(9):772-82. PubMed ID: 15750615
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Generation of an optimized polyvalent monocyte-derived dendritic cell vaccine by transfecting defined RNAs after rather than before maturation.
    Schaft N, Dörrie J, Thumann P, Beck VE, Müller I, Schultz ES, Kämpgen E, Dieckmann D, Schuler G.
    J Immunol; 2005 Mar 01; 174(5):3087-97. PubMed ID: 15728524
    [Abstract] [Full Text] [Related]

  • 10. Monocyte enrichment from leukapheresis products by using the Elutra cell separator.
    Kim S, Kim HO, Baek EJ, Choi Y, Kim HS, Lee MG.
    Transfusion; 2007 Dec 01; 47(12):2290-6. PubMed ID: 17764512
    [Abstract] [Full Text] [Related]

  • 11. An improved protocol for generation of immuno-potent dendritic cells through direct electroporation of CD14+ monocytes.
    Milano F, van Baal JW, Rygiel AM, Bergman JJ, Van Deventer SJ, Kapsenberg ML, Peppelenbosch MP, Krishnadath KK.
    J Immunol Methods; 2007 Apr 10; 321(1-2):94-106. PubMed ID: 17336322
    [Abstract] [Full Text] [Related]

  • 12. Enhanced dendritic cell antigen presentation in RNA-based immunotherapy.
    Kalady MF, Onaitis MW, Padilla KM, Emani S, Tyler DS, Pruitt SK.
    J Surg Res; 2002 Jun 01; 105(1):17-24. PubMed ID: 12069496
    [Abstract] [Full Text] [Related]

  • 13. High transfection efficiency, gene expression, and viability of monocyte-derived human dendritic cells after nonviral gene transfer.
    Landi A, Babiuk LA, van Drunen Littel-van den Hurk S.
    J Leukoc Biol; 2007 Oct 01; 82(4):849-60. PubMed ID: 17626798
    [Abstract] [Full Text] [Related]

  • 14. Nonviral transfection of distinct types of human dendritic cells: high-efficiency gene transfer by electroporation into hematopoietic progenitor- but not monocyte-derived dendritic cells.
    Van Tendeloo VF, Snoeck HW, Lardon F, Vanham GL, Nijs G, Lenjou M, Hendriks L, Van Broeckhoven C, Moulijn A, Rodrigus I, Verdonk P, Van Bockstaele DR, Berneman ZN.
    Gene Ther; 1998 May 01; 5(5):700-7. PubMed ID: 9797876
    [Abstract] [Full Text] [Related]

  • 15. Clinical-scale elutriation as a means of enriching antigen-presenting cells and manipulating alloreactivity.
    Micklethwaite KP, Garvin FM, Kariotis MR, Yee LL, Hansen AM, Antonenas V, Sartor MM, Turtle CJ, Gottlieb DJ.
    Cytotherapy; 2009 May 01; 11(2):218-28. PubMed ID: 19242837
    [Abstract] [Full Text] [Related]

  • 16. Side-by-side comparison of lentivirally transduced and mRNA-electroporated dendritic cells: implications for cancer immunotherapy protocols.
    Dullaers M, Breckpot K, Van Meirvenne S, Bonehill A, Tuyaerts S, Michiels A, Straetman L, Heirman C, De Greef C, Van Der Bruggen P, Thielemans K.
    Mol Ther; 2004 Oct 01; 10(4):768-79. PubMed ID: 15451461
    [Abstract] [Full Text] [Related]

  • 17. Optimizing the exogenous antigen loading of monocyte-derived dendritic cells.
    Dieckmann D, Schultz ES, Ring B, Chames P, Held G, Hoogenboom HR, Schuler G.
    Int Immunol; 2005 May 01; 17(5):621-35. PubMed ID: 15824067
    [Abstract] [Full Text] [Related]

  • 18. Generation of human dendritic cells that simultaneously secrete IL-12 and have migratory capacity by adenoviral gene transfer of hCD40L in combination with IFN-gamma.
    Knippertz I, Hesse A, Schunder T, Kämpgen E, Brenner MK, Schuler G, Steinkasserer A, Nettelbeck DM.
    J Immunother; 2009 Jun 01; 32(5):524-38. PubMed ID: 19609245
    [Abstract] [Full Text] [Related]

  • 19. Generation of DC-based vaccine for therapy of B-CLL patients. Comparison of two methods for enriching monocytic precursors.
    Kokhaei P, Adamson L, Palma M, Osterborg A, Pisa P, Choudhury A, Mellstedt H.
    Cytotherapy; 2006 Jun 01; 8(4):318-26. PubMed ID: 16923607
    [Abstract] [Full Text] [Related]

  • 20. mRNA transfection of DC in the immature or mature state: comparable in vitro priming of Th and cytotoxic T lymphocytes against DC electroporated with tumor cell line-derived mRNA.
    Jarnjak-Jankovic S, Saebøe-Larssen S, Kvalheim G, Gaudernack G.
    Cytotherapy; 2007 Jun 01; 9(6):587-92. PubMed ID: 17882723
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.